Floatz logo

Tebentafusp

Uveal Melanoma

H. Lee Moffitt Cancer Center and Research Instituteprotein_peptidePhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
81/ 100

Competitive context

63 Active assets in the Uveal Melanoma cohort.

Asset / SponsorPhaseRating
Ifa
Craig L Slingluff, Jr
Phase 2BBB
Tyrosinase Peptide
University of Southern California
Phase 3BB
Sargramostim
Thomas Jefferson University
Phase 3BB
Cyclophosphamide
Beijing Biotech
Phase 2/3BB
Darovasertib
IDEAYA Biosciences
Phase 3BB

View all 50 →

Same molecule, other indications

Tebentafusp is also rated in:

melanomaDormant
BB
Indicative ·
70 / 100
View asset →
cutaneous melanomaDormant
CCC
Indicative ·
53 / 100
View asset →
Select Advanced Solid TumorsDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →